The miR Sentinel™ Prostate Cancer Test is a standalone, non-invasive liquid biopsy urine test that detects, classifies and can monitor prostate cancer at the molecular level.
Prostate cancer is prevalent and deadly.
It represents the highest number of new cancer cases diagnosed annually and is the second leading cause of cancer deaths among men. Early detection and the ability to identify high grade disease early are key to effective disease management.
Until now, no effective, accurate and non-invasive tests had been developed for the early detection and grade classification of prostate cancer.
.png)
Prostate cancer is prevalent and deadly.
It represents the highest number of new cancer cases diagnosed annually and is the second leading cause of cancer deaths among American men. Early detection and the ability to identify high grade disease early are key to effective disease management: If detected early, the survival rate is nearly 100%, but a late diagnosis drops survival to only 30%.
Unlike other cancers, a significant proportion of prostate cancers are indolent and are unlikely to need immediate treatment, and only a relatively small number of prostate cancer patients have an aggressive disease that requires intervention.
Invasive, expensive and inaccurate with 44% sensitivity.
Primary Care Visit
Urologist Visit
Multiple Digital Rectal Exams
Multiple PSA Blood Tests
1 or More Prostate Biopsies
(Excluding New York, California, Maryland, Rhode Island, Pennsylvania)
Download Brochure
Book an appointment with your medical provider and request a prescription for the miR Sentinel™ Prostate Cancer Test.
Give a simple urine sample
in your provider’s office.
Your provider will receive comprehensive and accurate results--together you will discuss their meaning and next steps.
Diagnose and classify prostate cancer accurately with the miR Sentinel™ Prostate Cancer Test: a breakthrough, pain-free, comprehensive,
simple urine test
.png)
Until now, prostate cancer screening and diagnosis involved a complex and painful process including multiple procedures, many of which are inaccurate, invasive and ultimately don’t easily answer your two most crucial questions: Do I have prostate cancer? How severe is it? These painful and highly inaccurate procedures cause too many men to opt out of screening for prostate cancer, putting their health at risk.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna
aliqua.
The report will be securely delivered to the provider who ordered the test, either via secure fax or email.
The miR Sentinel™ Prostate Cancer Test is commercially available in most US states as well as Puerto Rico. The Test is not currently available in New York, California, Pennsylvania, Maryland and Washington, D.C. We are working to bring miR Sentinel™ to all 50 U.S. states, all territories and global markets including Canada, Israel and Singapore.
miR Scientific Collection Kits can be ordered by a healthcare provider over the phone, by contacting miR Scientific’s customer service team at 1-855-55CALLMIR.
miR Scientific is currently exploring insurance coverage and Medicare reimbursement with several carriers in the US and Puerto Rico but is currently an out-of-network provider. Patients will have the option of paying with credit card or we can assist with submitting out-of-network claims to their carrier. We do offer a patient assistance program called miR Access™ to support access to the test for those in need here: https://www.mirsentinel.com/insurance-billing
miR's Sentinel™ Prostate Cancer Test is currently only available through a health care provider. Please speak with your physician about possible testing options.
We're here to help! Visit our support center for FAQs and options to connect with a miR Sentinel expert directly
SUPPORT CENTER
miR Scientific is committed to working with your insurer. For more information about billing and to log in to our patient portal, click below.
Reimbursement InfoLearn about our Payment Assistance Programs
Our unique process provides actionable data to providers far more quickly than today’s standard of care, rapidly accelerating the timeline to treatment or monitoring, if necessary.
The report will be securely delivered to the provider who ordered the test, either via secure fax or email.
The miR Sentinel™ Prostate Cancer Test is commercially available in most US states as well as Puerto Rico. The Test is not currently available in New York, California, Pennsylvania, Maryland and Washington, D.C. We are working to bring miR Sentinel™ to all 50 U.S. states, all territories and global markets including Canada, Israel and Singapore.
miR Scientific Collection Kits can be ordered by a healthcare provider over the phone, by contacting miR Scientific’s customer service team at 1-855-55CALLMIR.
miR Scientific is currently exploring insurance coverage and Medicare reimbursement with several carriers in the US and Puerto Rico but is currently an out-of-network provider. Patients will have the option of paying with credit card or we can assist with submitting out-of-network claims to their carrier. We do offer a patient assistance program called miR Access™ to support access to the test for those in need here: https://www.mirsentinel.com/insurance-billing
miR's Sentinel™ Prostate Cancer Test is currently only available through a health care provider. Please speak with your physician about possible testing options.
We're here to help! Visit our support center for FAQs and options to connect with a miR Sentinel expert directly.
SUPPORT CENTER
